Human germline genome editing with CRISPR–Cas9 can be used with high efficiency, accuracy, and safety to correct a heterozygous, autosomal dominant mutation in MYBPC3 associated with hypertrophic cardiomyopathy, according to a new study in Nature.CRISPR–Cas9 is a versatile tool for recognizing a

中文翻译：

---

遗传学：心脏病中的人类基因组编辑

根据Nature上的一项新研究，使用CRISPR–Cas9进行人类种系基因组编辑可以高效，准确和安全地用于纠正与肥厚型心肌病相关的MYBPC3中的杂合，常染色体显性突变。认识到